icon-star icon-bag icon-search icon-close icon-list icon-plus minus icon-loading arrow-left arrow-right chevron-left chevron-right mail linkedin facebook instagram pinterest tumblr youtube twitter stumbleupon google print rss heart share icon-visa icon-mastercard icon-american-express icon-discover icon-paypal icon-apple-pay icon-stripe
Menu
  • Company
    • About
    • Bios
  • Technology
  • Products
  • Studies
    • Testimonials
    • Data
  • Markets
    • Non-Clinical
    • Cornea Transplantation
  • News
  • Contact Us
CryoCrate, LLC
  • Your bag is currently empty.

    • Log In
    • Sign Up

News

CryoCrate LLC received a $1.5 million NIH SBIR Phase II grant to produce, test and commercialize “INSTAvitria™”, a novel tissue cryopreservation device system CryoCrate LLC received a $1.5 million NIH SBIR Phase II grant to produce, test and commercialize “INSTAvitria™”, a novel tissue cryopreservation device system src="https://cdn11.bigcommerce.com/s-102735myp2/images/stencil/original/uploaded_images/cryo-crate-logo-tn.jpg?t=1572299647" >

CryoCrate LLC received a $1.5 million NIH SBIR Phase II grant to produce, test and commercialize “INSTAvitria™”, a novel tissue cryopreservation device system

Sep 1st 2019

Danforth Investigation for Preserving Sf9 Cells Danforth Investigation for Preserving Sf9 Cells src="https://cdn11.bigcommerce.com/s-102735myp2/images/stencil/original/uploaded_images/601001-c80ez-insect.jpg?t=1572299682" >

Danforth Investigation for Preserving Sf9 Cells

Feb 15th 2018

CryoCrate, LLC
  • 1601 S. Providence Road, Columbia, MO 65211 | Phone: 636-266-2047

    © CryoCrate, LLC. All Rights reserved.